Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Joachim Gerß"'
Autor:
Joachim Gerss, Kornelius Kerl, Maria Joao Gil da Costa, Marcus Jakob, Ulrich Schüller, Karolina Nemes, Astrid Sehested, Thomas Kröncke, Reiner Siebert, Pascal Johann, Michael C. Frühwald, David Sumerauer, Simone Hettmer, Olaf Witt, Harald Reinhard, Martin Ebinger, Stefanie Tüchert, Peter Hauser, Mona Steinbügl, Martin Hasselblatt
Publikováno v:
Pediatric Blood & Cancer. 68
Background Refined therapy has helped to improve survival rates in rhabdoid tumors (RT). Prognosis for patients with chemoresistant, recurrent, or progressive RT remains dismal. Although decitabine, an epigenetically active agent, has mainly been eva
Autor:
Anja Möricke, Katharina Speitel, Joachim Gerss, Joachim Boos, Claudia Lanvers-Kaminsky, Dominik Schrey
Publikováno v:
Pediatric Blood & Cancer. 57:378-384
Background Therapeutic drug monitoring (TDM) of asparaginase (ASNase), a fundamental element of acute lymphoblastic leukemia treatment, was integrated in the ALL-BFM 2000 protocol on a voluntary basis. Methods Over a 5-year period, 127 patients (1,35
Autor:
Georg Hempel, Anja Möricke, Stephan Borghorst, Joachim Gerss, Joachim Boos, Martin Schrappe, Dominik Schrey, Claudia Lanvers-Kaminsky
Publikováno v:
Pediatric Blood & Cancer. 54:952-958
Background On a voluntary basis therapeutic drug monitoring (TDM) was implemented in the ALL-BFM 2000 protocol for the three currently used asparaginase (ASNase) preparations (first line: native Escherichia coli ASNase; second line: pegylated ASNase
Autor:
Jörg Mühlisch, Sabine Wagner, Johannes E. A. Wolff, Martin Hasselblatt, Michael C. Frühwald, Sabrina Schlosser, Joachim Gerß
Publikováno v:
Pediatric Blood & Cancer.
Background Studies in adults with malignant glioma suggest MGMT methylation as a stratification marker. Similar data for children are sparse. We investigated the impact of MGMT methylation and expression on survival of children with high-grade glioma